Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Nov 7;12(11):1878-1880.
doi: 10.2215/CJN.09000817. Epub 2017 Oct 3.

Being Thoughtful about Desensitization

Richard N Formica Jr  1   2 , Sanjay Kulkarni  1   2
Affiliations
Comment

Being Thoughtful about Desensitization

Richard N Formica Jr et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: Desensitization; Donor Specific antibody; Highly sensitized; kidney transplantation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Estimated waiting time until deceased donor kidney transplantation among very highly sensitized candidates (those with calculated panel reactive antibodies 98%–100%) before and after implementation of the new kidney allocation system (KAS). Reprinted from ref. , with permission.
See this image and copyright information in PMC

Comment in

Comment on

  • IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
    Jordan SC, Lorant T, Choi J, Kjellman C, Winstedt L, Bengtsson M, Zhang X, Eich T, Toyoda M, Eriksson BM, Ge S, Peng A, Järnum S, Wood KJ, Lundgren T, Wennberg L, Bäckman L, Larsson E, Villicana R, Kahwaji J, Louie S, Kang A, Haas M, Nast C, Vo A, Tufveson G. Jordan SC, et al. N Engl J Med. 2017 Aug 3;377(5):442-453. doi: 10.1056/NEJMoa1612567. N Engl J Med. 2017. PMID: 28767349 Clinical Trial.

References

    1. Jordan SC, Lorant T, Choi J, Kjellman C, Winstedt L, Bengtsson M, Zhang X, Eich T, Toyoda M, Eriksson BM, Ge S, Peng A, Järnum S, Wood KJ, Lundgren T, Wennberg L, Bäckman L, Larsson E, Villicana R, Kahwaji J, Louie S, Kang A, Haas M, Nast C, Vo A, Tufveson G: IgG endopeptidase in highly sensitized patients undergoing transplantation. N Engl J Med 377: 442–453, 2017 - PubMed
    1. Orandi BJ, Luo X, Massie AB, Garonzik-Wang JM, Lonze BE, Ahmed R, Van Arendonk KJ, Stegall MD, Jordan SC, Oberholzer J, Dunn TB, Ratner LE, Kapur S, Pelletier RP, Roberts JP, Melcher ML, Singh P, Sudan DL, Posner MP, El-Amm JM, Shapiro R, Cooper M, Lipkowitz GS, Rees MA, Marsh CL, Sankari BR, Gerber DA, Nelson PW, Wellen J, Bozorgzadeh A, Gaber AO, Montgomery RA, Segev DL: Survival benefit with kidney transplants from HLA-incompatible live donors. N Engl J Med 374: 940–950, 2016 - PMC - PubMed
    1. Stewart DE, Kucheryavaya AY, Klassen DK, Turgeon NA, Formica RN, Aeder MI: Changes in deceased donor kidney transplantation one year after KAS implementation. Am J Transplant 16: 1834–1847, 2016 - PubMed
    1. Stewart DE, Klassen DK: Kidney transplants from HLA-incompatible live donors and survival. N Engl J Med 375: 287–288, 2016 - PubMed
    1. Stegall MD, Gloor J, Winters JL, Moore SB, Degoey S: A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 6: 346–351, 2006 - PubMed